Cycle view
- Bloc
- Organisation
- Théorie
- Pratique
- Autres
- Crédits
| Code | Détails | Bloc | Organisation | Théorie | Pratique | Autres | Crédits |
|---|---|---|---|---|---|---|---|
| LANG0130-1 | Scientific English Practice (note-taking) | B1 | Q1 | 5 | 25 | - | 3 |
| LABO0432-1 | Techniques for cells and tissue cultures | B1 | Q1 | 5 | 20 | - | 2 |
| COMU0430-2 | Techniques de communication | B1 | Q1 | 10 | 25 | - | 2 |
| SBIM0486-2 | Experimental methodologies in living animals | B1 | Q1 | 25 | 10 | - | 4 |
| BIOL0431-2 | Complement of normal and pathological cellular regulation | B1 | Q1 | 20 | - | - | 3 |
| LABO0433-2 | Modern morphological methods in biomedical research | B1 | Q1 | 15 | 5 | - | 2 |
| SANG0430-2 | Hematology and haemostasis | B1 | Q1 | 20 | - | - | 2 |
| INFO0430-2 | Notions of bioinformatics | B1 | Q1 | 10 | 10 | - | 2 |
| GENE0431-1 | Complement of genomics | B1 | Q1 | 20 | 10 | - | 3 |
| STAT0420-1 | Biostatistics 2 | B1 | Q1 | 15 | 15 | - | 2 |
| RADL0440-1 | Radiobiology | B1 | Q2 | 30 | 10 | - | 3 |
| CHIM0440-2 | Clinical chemistry | B1 | Q2 | 20 | 10 | - | 3 |
| TOXI0432-1 | Complement of toxicology | B1 | Q2 | 10 | 10 | - | 2 |
| CHIM0433-1 | Proteomics | B1 | Q2 | 20 | 10 | - | 3 |
| NEUR0432-1 | Complement of neurobiology | B1 | Q2 | 20 | 10 | - | 3 |
| METO0822-1 | Introduction to translational research | B1 | Q2 | 30 | - | - | 2 |
| STAT1750-1 | Multivariate statistical analysis | B2 | Q1 | 10 | 15 | - | 2 |
| MMEM0440-1 | Final thesis
Collégialité
Prerequisite
| B2 | Q2 | - | - | - | 28 |
Specific Module |
|||||||
| MSTG0430-3 | Placement in laboratory - [140h internship]
Collégialité
| B1 | Q2 | 5 | - | [+] | 15 |
Optional courses
- B1
- 4Cr
- B2
- 30Cr
| Code | Détails | Bloc | Organisation | Théorie | Pratique | Autres | Crédits |
|---|---|---|---|---|---|---|---|
| BIOC0210-5 | Functional properties of biological macromolecules - [10h Monitored workshops] | B1 | Q1 | 20 | - | [+] | 2 |
| BIOC0720-2 | Structure of biological macromolecules - [5h Monitored workshops] | B1 | Q1 | 15 | - | [+] | 2 |
| BIOC0709-4 | Bioenergetics | B1 | Q1 | 20 | - | - | 2 |
| BIOC0725-1 | Stem Cell Biology | B1 | Q1 | 20 | - | - | 2 |
| Code | Détails | Bloc | Organisation | Théorie | Pratique | Autres | Crédits |
|---|---|---|---|---|---|---|---|
| BIOC0722-1 | Application of spectroscopic techniques to the study of folding and stability of proteins - [10h Monitored workshops] | B1 | Q2 | 20 | - | [+] | 2 |
| CHIM0687-1 | Introduction to protein NMR - [10h Monitored workshops] | B1 | Q2 | 10 | - | [+] | 2 |
| CHIM0688-1 | Mass spectrometry - [10h Monitored workshops] | B1 | Q2 | 15 | - | [+] | 2 |
| BIOL2029-1 | Introduction to clinical biology | B1 | Q2 | 20 | - | - | 2 |
Choose one focus from the following :
- B2
- 1Nbr
| Code | Détails | Bloc | Organisation | Théorie | Pratique | Autres | Crédits | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Choose one option from the following :
|
A. Digestive system and nutrition - Coordinator: Nicolas PaquotNotice : all courses in this option could be given in English. |
SBIM0430-1 | Methods in vivo and in vitro concerning gastrointestinal tract
| B2 | Q1 | 15 | 10 | - | 4 |
SBIM0431-1 | Diseases of the digestive tract and food allergies/intolerances. Pediatric and adult aspects
| B2 | Q1 | 30 | - | - | 4 |
NUTR0711-1 | Nutrition and dietetic elements
| B2 | Q1 | 10 | - | - | 4 |
NUTR0712-1 | Nutrition and pathologies
| B2 | Q1 | 10 | - | - | 4 |
NUTR1001-1 | Food - Health
| Corequisite
B2 | Q1 | 20 | - | - | 3 |
QUAL0436-1 | Quality assurance linked to foodstuffs | B2 | Q1 | 2 |
partim I : aspects chimiques
| | | 7,5 | - | - | |
partim II : aspects biologiques
| | | 7,5 | - | - | |
SBIM0434-1 | Phytochemical introduction to the analysis of foodstuffs
| B2 | Q1 | 10 | - | - | 2 |
SBIM0436-1 | Dietary technology, legislation and labelling
| Corequisite
B2 | Q1 | 15 | - | - | 2 |
SBIM0437-4 | Biosafety
| B2 | Q1 | 10 | 5 | - | 1 |
SBIM0439-1 | Bibliographic research
| Prerequisite
B2 | TA | - | - | - | 4 |
|
B. Biological analyses - Coordinator : Etienne CavalierNotice : Courses QUAL0430, MICR0431, SBIM0450, SBIM0452, SBIM0453, SBIM0454, SBIM0437 could be given in English. |
QUAL0430-2 | Quality assurance systems in clinical biology
| Prerequisite
B2 | Q1 | 10 | 5 | - | 3 |
MICR0431-2 | Clinical microbiology
| B2 | Q1 | 15 | 10 | - | 3 |
IMMU0430-1 | Immunoassay
| B2 | Q1 | 5 | 10 | - | 3 |
SBIM0450-1 | Complement of clinical chemistry
| Prerequisite
B2 | Q1 | 15 | 10 | - | 4 |
SBIM0451-2 | Diagnostic moléculaire
| Frédéric Lambert, Marie-Paule Merville
B2 | Q1 | 15 | 25 | - | 4 |
SBIM0452-1 | Cellular and molecular biology of acute and chronic inflammation
| B2 | Q1 | 15 | - | - | 3 |
SBIM0453-1 | Complement of haematology
| Prerequisite
B2 | Q1 | 15 | - | - | 3 |
SBIM0454-1 | Monitoring renal pathologies
| Prerequisite
B2 | Q1 | 10 | - | - | 2 |
SBIM0437-4 | Biosafety
| B2 | Q1 | 10 | 5 | - | 1 |
SBIM0439-1 | Bibliographic research
| Prerequisite
B2 | TA | - | - | - | 4 |
|
C. Pharmacology and toxicology - Coordinator : Julien HansonNotice : courses PHAC0430, EPID0441, METO0441, SBIM0461, SBIM0437 could be given in English. |
PHAC0430-2 | Special pharmacology
| Corequisite
B2 | Q1 | 30 | - | - | 4 |
EPID0430-1 | Methodology of Clinical Trials
| B2 | Q1 | 10 | - | - | 2 |
EPID0441-1 | Pharmaco-epidemiology and Pharmaco-economics
| B2 | Q1 | 10 | - | - | 2 |
TOXI0441-1 | Experimental Toxicology
| Prerequisite
B2 | Q1 | 10 | - | - | 2 |
METO0441-1 | Methodology of Pharmaceutical Research
| B2 | Q1 | 15 | 10 | - | 3 |
SBIM0460-1 | Introduction to the Pharmaceutical Technology
| B2 | Q1 | 15 | 10 | - | 3 |
BIOL2025-1 | Medical and pharmaceutical applications in molecular biology
| B2 | Q1 | 10 | - | - | 2 |
SBIM0461-1 | Radiomarking and the medical and experimental use of tracers
| B2 | Q1 | 10 | - | - | 2 |
SBIM0462-1 | Pharmacology and addiction clinic
| B2 | Q1 | 10 | - | - | 2 |
SBIM0463-1 | Biocompatibility of implants and biomaterials
| B2 | Q1 | 25 | - | - | 3 |
SBIM0437-4 | Biosafety
| B2 | Q1 | 10 | 5 | - | 1 |
SBIM0439-1 | Bibliographic research
| Prerequisite
B2 | TA | - | - | - | 4 |
|
D. Neurosciences - Coordinator : Rachelle FranzenNotice : courses SBIM0471, SBIM0472, SBIM0474, SBIM0477 could be given in English. |
SBIM0470-1 | Principles of neuroendocrinology
| B2 | Q1 | 20 | - | - | 3 |
SBIM0472-1 | In vivo methodology in neuroscience
| Prerequisite
B2 | Q1 | 20 | - | - | 3 |
SBIM0473-1 | Functional neuro-anatomy in vertebrates
| Prerequisite
B2 | Q1 | 30 | - | - | 3 |
SBIM0474-1 | Biophysics and molecular biology of ion channels
| B2 | Q1 | 20 | - | - | 3 |
SBIM0475-1 | Pathologies of the nervous system
| Prerequisite
B2 | Q1 | 20 | 10 | - | 4 |
PSYC0908-1 | Psychobiological questions
| B2 | Q2 | 20 | - | - | 3 |
SBIM0477-1 | Functional imagery in humans
| B2 | Q1 | 20 | - | - | 3 |
SBIM0437-4 | Biosafety
| B2 | Q1 | 10 | 5 | - | 1 |
SBIM0001-1 | Neuro-inflammation and neuroimmunology
| Virginie Neirinckx , Priscilla Van Den Ackerveken
B2 | Q1 | 15 | - | - | 3 |
SBIM0439-1 | Bibliographic research
| Prerequisite
B2 | TA | - | - | - | 4 |
|
F. Oncology and immunology - Coordinator : Agnès NoëlNotice : Courses SBIM0480, SBIM0483, SBIM0484, SBIM0437 could be given in English. |
SBIM0480-2 | Anatomical pathology of tumours
| B2 | Q1 | 15 | 15 | - | 4 |
SBIM0481-2 | Molecular and cellular oncology - [35h Seminar]
| Prerequisite
B2 | Q1 | 15 | - | [+] | 6 |
SBIM0482-2 | Vaccination - [15h Seminar]
|
Laurence Delacroix, N...
B2 | Q1 | 10 | 5 | [+] | 4 |
SBIM0483-1 | Cytokine chemokine signalling - [5h Seminar]
| Andy Chevigné
B2 | Q1 | 10 | - | [+] | 3 |
SBIM0484-1 | Immunology of tumours - [10h Seminar]
| B2 | Q1 | 10 | - | [+] | 3 |
SBIM0492-1 | Preclinical cancer models - [10h Seminar]
| B2 | Q1 | 5 | - | [+] | 3 |
SBIM0437-4 | Biosafety
| B2 | Q1 | 10 | 5 | - | 1 |
SBIM2001-1 | Métabolisme du cancer
| B2 | Q1 | 15 | - | - | 2 |
SBIM0439-1 | Bibliographic research
| Prerequisite
B2 | TA | - | - | - | 4 |
|
F. Multidisciplinary English - Coordinator : Vincent SeutinNotice : all courses will be given in English. |
SBIM0494-1 | General introduction to cell biology (english language) - [15h Monitored workshops, 15h Personal research]
| Prerequisite
B2 | Q1 | 16 | - | [+] | 4 |
SBIM0495-1 | Molecular and cellular basis of disease (english language) - [10h Monitored workshops, 40h Personal research]
| B2 | Q1 | 20 | - | [+] | 7 |
SBIM0496-1 | Advanced techniques for diagnosis and prognosis (english language) - [10h Monitored workshops, 40h Personal research]
| Prerequisite
B2 | Q1 | 10 | - | [+] | 5 |
SBIM0497-1 | New therapeutic approaches to disease (english language) - [10h Monitored workshops, 40h Personal research]
| B2 | Q1 | 10 | - | [+] | 5 |
SBIM0498-1 | Critical evaluation of experimental data (english language) - [10h Monitored workshops, 10h Personal research]
| B2 | Q1 | 10 | 20 | [+] | 4 |
SBIM0499-1 | Thematic seminars (english language) - [20h Seminar]
| B2 | Q1 | - | - | [+] | 5 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Code | Détails | Bloc | Organisation | Théorie | Pratique | Autres | Crédits |
|---|---|---|---|---|---|---|---|
| Notice : Some courses listed below may be given in English. | |||||||
| Coordinator : Philippe HUBERT | |||||||
| QUAL0431-1 | Internal and external audits | B2 | Q1 | 10 | 20 | - | 3 |
| QUAL0432-1 | Quality Assurance for IT systems
Marc Denham
| B2 | Q1 | 5 | - | - | 1 |
| QUAL0433-1 | Organisation and quality assurance in a trial laboratory | B2 | Q1 | 5 | 10 | - | 3 |
| QUAL0434-1 | Validation of quantitative analysis methods | B2 | Q1 | 10 | 10 | - | 2 |
| QUAL0435-1 | Microbiological quality assurance of the environment | B2 | Q1 | 10 | 15 | - | 3 |
| QUAL0436-1 | Quality assurance linked to foodstuffs | B2 | Q1 | 2 | |||
| partim I : aspects chimiques | 7,5 | - | - | ||||
| partim II : aspects biologiques | 7,5 | - | - | ||||
| ESHY0057-1 | General Safety Organization | B2 | Q1 | 14 | - | - | 2 |
| QUAL0437-2 | Statistical data analysis using informatic tools | B2 | Q1 | 15 | 20 | - | 2 |
| GEST0188-1 | Determination and Recognition of Quality and Conformity | B2 | Q1 | 30 | - | - | 3 |
| QUAL0430-1 | Quality assurance systems in clinical biology | B2 | Q1 | 10 | - | - | 2 |
| QUAL0438-1 | Good Manufacturing Pratices (GMP) (english language) | B2 | Q1 | 10 | 10 | - | 2 |
| QUAL0439-1 | Chemical quality assurance of the environment | B2 | Q1 | 15 | 15 | - | 3 |
| GEST2002-1 | Integrated approach to assessing the quality of care
Marie Erpicum, Jean-Bernard Gillet, Pierre Gillet
| B2 | Q1 | 4 | 16 | - | 2 |
| Code | Détails | Bloc | Organisation | Théorie | Pratique | Autres | Crédits | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||